Johnson & Johnson Stock Price Targets

Comprehensive analysis of short, mid, and long-term price targets for Johnson & Johnson (JNJ).

Give me a comprehensive price target analysis for Johnson & Johnson (JNJ).

Price Target Analysis for Johnson & Johnson (JNJ)

Target LevelPrice ($)Justification & Drivers
Low Target155.00The low target aligns with the recent analyst consensus and provides a sturdy support zone. The stock is currently trading above this level, with technical indicators (like the 50-day MA around 154.3) supporting this support. Risks include potential market volatility or sector-specific headwinds.
Median Target175.00The median target reflects the consensus of 23 analysts, slightly below the current market price. The stock exhibits positive momentum with an upward trend in EPS, healthy margins, and technical indicators (like RSI and MACD) suggesting sustained strength. Opportunities include continued earnings growth and stable dividend yield.
High Target200.00The high target factors in the best-case scenario driven by robust earnings growth, potential positive sector developments, and a strong technical breakout (with recent upward momentum in MACD and RSI). If the stock escalates, it might challenge resistance at around $200, offering significant upside potential. Possible catalysts include new product pipelines or macroeconomic tailwinds.

Summary

Johnson & Johnson (JNJ) currently trades at approximately $178.93, with a strong fundamental profile and technical signals indicating bullish momentum. The stock’s valuation metrics (P/E ~19, P/B ~5.5) suggest moderate premium relative to peers, supported by solid margins, low beta (0.399), and consistent dividend yields.

The drawn support and resistance levels at $155, $175, and $200 provide clear technical benchmarks, with strategic importance for short to long-term investors. The forthcoming months could see the stock testing these levels contingent on earnings performance and broader market conditions.


Would you like a more detailed technical analysis or any specific segment expanded?

Chart is loading...